(Q46006952)

18 December 2017

title

Significance of mycophenolate monitoring in liver transplant recipients: toward the cut-off level. (English)

1 reference

18 December 2017

author name string

E Sarvary

1

1 reference

18 December 2017

B Nemes

2

1 reference

18 December 2017

M Varga

3

1 reference

18 December 2017

I Gaal

4

1 reference

18 December 2017

K Monostory

5

1 reference

18 December 2017

R M Langer

6

1 reference

18 December 2017

D Gorog

7

1 reference

18 December 2017

J Fazakas

8

1 reference

18 December 2017

L Kobori

9

1 reference

18 December 2017

I Fehervari

10

1 reference

18 December 2017

Zs Gerlei

11

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

18 December 2017

Transplantation Proceedings

published in

1 reference

18 December 2017

volume

44

1 reference

18 December 2017

issue

7

1 reference

18 December 2017

page(s)

2157-2161

1 reference

18 December 2017

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Therapeutic monitoring of mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

The inhibition of nucleic acid synthesis by mycophenolic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Monitoring mycophenolic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Mycophenolate blood level monitoring: recent progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

The evolution of therapeutic immunosuppression and the potential impact of drug concentration monitoring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Therapeutic monitoring of tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Therapeutic drug monitoring of mycophenolate mofetil in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.124

10.1016/J.TRANSPROCEED.2012.07.124

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017